Subscribe To
Opendoor: low-margin, asset-intensive businesses can succeed
Opendoor: Low-Margin, Asset-intensive Businesses Can Succeed...
February 10, 2022, 2:49 am
Opendoor: low-margin, asset-intensive businesses can succeed
Opendoor: Low-Margin, Asset-intensive Businesses Can Succeed...
February 10, 2022, 2:49 am
Descartes sets date to announce fiscal 2022 fourth quarter and year-end financial results
WATERLOO, Ontario, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX:DSG) (Nasdaq:DSGX), the global leader in uniting logistics-...
February 2, 2022, 6:45 am
Descartes sets date to announce fiscal 2022 fourth quarter and year-end financial results
WATERLOO, Ontario, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX:DSG) (Nasdaq:DSGX), the global leader in uniting logistics-...
February 2, 2022, 6:45 am
Descartes sets date to announce fiscal 2022 fourth quarter and year-end financial results
WATERLOO, Ontario, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX:DSG) (Nasdaq:DSGX), the global leader in uniting logistics-...
February 2, 2022, 6:45 am
Apollon formularies names dr archibald mcdonald as clinical trials director
Apollon Formularies PLC (AQSE:APOL) said it appointed Dr Archibald McDonald as its director of clinical trials. McDonald is a surgeon and has served i...
January 21, 2022, 7:57 am
Apollon formularies names dr archibald mcdonald as clinical trials director
Apollon Formularies PLC (AQSE:APOL) said it appointed Dr Archibald McDonald as its director of clinical trials. McDonald is a surgeon and has served i...
January 21, 2022, 7:57 am
Apollon formularies names dr archibald mcdonald as clinical trials director
Apollon Formularies PLC (AQSE:APOL) said it appointed Dr Archibald McDonald as its director of clinical trials. McDonald is a surgeon and has served i...
January 21, 2022, 7:57 am
Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference
MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...
October 7, 2021, 3:11 pm
Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference
MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...
October 7, 2021, 3:11 pm
Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference
MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...
October 7, 2021, 3:11 pm
Descartes unveils artificial intelligence and machine learning enhancements to routing, mobile & telematics suite
WATERLOO, Ontario, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-...
October 6, 2021, 6:45 am
Descartes unveils artificial intelligence and machine learning enhancements to routing, mobile & telematics suite
WATERLOO, Ontario, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-...
October 6, 2021, 6:45 am
Descartes unveils artificial intelligence and machine learning enhancements to routing, mobile & telematics suite
WATERLOO, Ontario, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-...
October 6, 2021, 6:45 am